389 related articles for article (PubMed ID: 23379478)
1. Bioengineering of AAV2 capsid at specific serine, threonine, or lysine residues improves its transduction efficiency in vitro and in vivo.
Gabriel N; Hareendran S; Sen D; Gadkari RA; Sudha G; Selot R; Hussain M; Dhaksnamoorthy R; Samuel R; Srinivasan N; Srivastava A; Jayandharan GR
Hum Gene Ther Methods; 2013 Apr; 24(2):80-93. PubMed ID: 23379478
[TBL] [Abstract][Full Text] [Related]
2. Targeted modifications in adeno-associated virus serotype 8 capsid improves its hepatic gene transfer efficiency in vivo.
Sen D; Gadkari RA; Sudha G; Gabriel N; Kumar YS; Selot R; Samuel R; Rajalingam S; Ramya V; Nair SC; Srinivasan N; Srivastava A; Jayandharan GR
Hum Gene Ther Methods; 2013 Apr; 24(2):104-16. PubMed ID: 23442071
[TBL] [Abstract][Full Text] [Related]
3. Optimization of the capsid of recombinant adeno-associated virus 2 (AAV2) vectors: the final threshold?
Aslanidi GV; Rivers AE; Ortiz L; Song L; Ling C; Govindasamy L; Van Vliet K; Tan M; Agbandje-McKenna M; Srivastava A
PLoS One; 2013; 8(3):e59142. PubMed ID: 23527116
[TBL] [Abstract][Full Text] [Related]
4. Site-Directed Mutagenesis of Surface-Exposed Lysine Residues Leads to Improved Transduction by AAV2, But Not AAV8, Vectors in Murine Hepatocytes In Vivo.
Li B; Ma W; Ling C; Van Vliet K; Huang LY; Agbandje-McKenna M; Srivastava A; Aslanidi GV
Hum Gene Ther Methods; 2015 Dec; 26(6):211-20. PubMed ID: 26421998
[TBL] [Abstract][Full Text] [Related]
5. Phase 1 gene therapy for Duchenne muscular dystrophy using a translational optimized AAV vector.
Bowles DE; McPhee SW; Li C; Gray SJ; Samulski JJ; Camp AS; Li J; Wang B; Monahan PE; Rabinowitz JE; Grieger JC; Govindasamy L; Agbandje-McKenna M; Xiao X; Samulski RJ
Mol Ther; 2012 Feb; 20(2):443-55. PubMed ID: 22068425
[TBL] [Abstract][Full Text] [Related]
6. Improved adeno-associated virus (AAV) serotype 1 and 5 vectors for gene therapy.
Sen D; Balakrishnan B; Gabriel N; Agrawal P; Roshini V; Samuel R; Srivastava A; Jayandharan GR
Sci Rep; 2013; 3():1832. PubMed ID: 23665951
[TBL] [Abstract][Full Text] [Related]
7. Chimeric Capsid Proteins Impact Transduction Efficiency of Haploid Adeno-Associated Virus Vectors.
Chai Z; Zhang X; Dobbins AL; Frost EA; Samulski RJ; Li C
Viruses; 2019 Dec; 11(12):. PubMed ID: 31835440
[TBL] [Abstract][Full Text] [Related]
8. Post-translational modifications in capsid proteins of recombinant adeno-associated virus (AAV) 1-rh10 serotypes.
Mary B; Maurya S; Arumugam S; Kumar V; Jayandharan GR
FEBS J; 2019 Dec; 286(24):4964-4981. PubMed ID: 31330090
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the Adeno-Associated Virus 1 and 6 Sialic Acid Binding Site.
Huang LY; Patel A; Ng R; Miller EB; Halder S; McKenna R; Asokan A; Agbandje-McKenna M
J Virol; 2016 Jun; 90(11):5219-5230. PubMed ID: 26962225
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of engineered AAV capsids for hepatic factor IX gene transfer in murine and canine models.
Markusic DM; Nichols TC; Merricks EP; Palaschak B; Zolotukhin I; Marsic D; Zolotukhin S; Srivastava A; Herzog RW
J Transl Med; 2017 May; 15(1):94. PubMed ID: 28460646
[TBL] [Abstract][Full Text] [Related]
11. Two novel adeno-associated viruses from cynomolgus monkey: pseudotyping characterization of capsid protein.
Mori S; Wang L; Takeuchi T; Kanda T
Virology; 2004 Dec; 330(2):375-83. PubMed ID: 15567432
[TBL] [Abstract][Full Text] [Related]
12. Comparative structural, biophysical, and receptor binding study of true type and wild type AAV2.
Bennett A; Hull J; Jolinon N; Tordo J; Moss K; Binns E; Mietzsch M; Hagemann C; Linden RM; Serio A; Chipman P; Sousa D; Broecker F; Seeberger P; Henckaerts E; McKenna R; Agbandje-McKenna M
J Struct Biol; 2021 Dec; 213(4):107795. PubMed ID: 34509611
[TBL] [Abstract][Full Text] [Related]
13. High-efficiency transduction of human monocyte-derived dendritic cells by capsid-modified recombinant AAV2 vectors.
Aslanidi GV; Rivers AE; Ortiz L; Govindasamy L; Ling C; Jayandharan GR; Zolotukhin S; Agbandje-McKenna M; Srivastava A
Vaccine; 2012 Jun; 30(26):3908-17. PubMed ID: 22497875
[TBL] [Abstract][Full Text] [Related]
14. The threefold protrusions of adeno-associated virus type 8 are involved in cell surface targeting as well as postattachment processing.
Raupp C; Naumer M; Müller OJ; Gurda BL; Agbandje-McKenna M; Kleinschmidt JA
J Virol; 2012 Sep; 86(17):9396-408. PubMed ID: 22718833
[TBL] [Abstract][Full Text] [Related]
15. Application of polyploid adeno-associated virus vectors for transduction enhancement and neutralizing antibody evasion.
Chai Z; Sun J; Rigsbee KM; Wang M; Samulski RJ; Li C
J Control Release; 2017 Sep; 262():348-356. PubMed ID: 28789965
[TBL] [Abstract][Full Text] [Related]
16. Engineered AAV vector minimizes in vivo targeting of transduced hepatocytes by capsid-specific CD8+ T cells.
Martino AT; Basner-Tschakarjan E; Markusic DM; Finn JD; Hinderer C; Zhou S; Ostrov DA; Srivastava A; Ertl HC; Terhorst C; High KA; Mingozzi F; Herzog RW
Blood; 2013 Mar; 121(12):2224-33. PubMed ID: 23325831
[TBL] [Abstract][Full Text] [Related]
17. Targeting photoreceptors via intravitreal delivery using novel, capsid-mutated AAV vectors.
Kay CN; Ryals RC; Aslanidi GV; Min SH; Ruan Q; Sun J; Dyka FM; Kasuga D; Ayala AE; Van Vliet K; Agbandje-McKenna M; Hauswirth WW; Boye SL; Boye SE
PLoS One; 2013; 8(4):e62097. PubMed ID: 23637972
[TBL] [Abstract][Full Text] [Related]
18. Molecular Engineering of Adeno-Associated Virus Capsid Improves Its Therapeutic Gene Transfer in Murine Models of Hemophilia and Retinal Degeneration.
Mary B; Maurya S; Kumar M; Bammidi S; Kumar V; Jayandharan GR
Mol Pharm; 2019 Nov; 16(11):4738-4750. PubMed ID: 31596095
[TBL] [Abstract][Full Text] [Related]
19. Next generation of adeno-associated virus 2 vectors: point mutations in tyrosines lead to high-efficiency transduction at lower doses.
Zhong L; Li B; Mah CS; Govindasamy L; Agbandje-McKenna M; Cooper M; Herzog RW; Zolotukhin I; Warrington KH; Weigel-Van Aken KA; Hobbs JA; Zolotukhin S; Muzyczka N; Srivastava A
Proc Natl Acad Sci U S A; 2008 Jun; 105(22):7827-32. PubMed ID: 18511559
[TBL] [Abstract][Full Text] [Related]
20. Mutagenesis of adeno-associated virus type 2 capsid protein VP1 uncovers new roles for basic amino acids in trafficking and cell-specific transduction.
Johnson JS; Li C; DiPrimio N; Weinberg MS; McCown TJ; Samulski RJ
J Virol; 2010 Sep; 84(17):8888-902. PubMed ID: 20573820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
